{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:01:05Z","timestamp":1792569665913,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Becker muscular dystrophy (BMD) is a rare X-linked recessive disorder associated with progressive physical disability, which may increase the risk of suicidal ideation. However, acute suicidal crises are rarely reported in BMD, as neuromuscular vulnerability restricts standard emergency pharmacological and somatic interventions. We describe an adolescent with BMD complicated by severe suicidal crisis to highlight key diagnostic and therapeutic considerations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 16-year-old boy, who was diagnosed with BMD at the age of 8, became socially isolated due to progressive muscle weakness and long-term home confinement. He had experienced depressed mood for 3 years and recurrent self-injurious behavior for 6 months before admission, eventually engaging in wrist-cutting and an attempted jump from a building. Psychological assessment revealed severe depression and anxiety. To avoid premature definitive classification during an acute crisis, the patient was managed under a broader working diagnosis of mood disorder. Treatment emphasized psychotherapy and family intervention, with adjunctive low-dose fluoxetine (20\u00a0mg\/day) and olanzapine (5\u00a0mg\/day) to control impulsivity while minimizing sedation-related worsening of muscle weakness. Suicidal ideation resolved within 5 days, and no further severe suicidal behavior occurred over 10 months of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Severe suicidal behavior in BMD highlights the profound psychiatric impact of progressive physical and social decline. In adolescents with BMD and severe suicidal behaviors, dynamic assessment and early crisis intervention are essential. Psychological and family-based interventions should be prioritized, while pharmacotherapy, when needed, should be used cautiously to avoid exacerbating underlying neuromuscular weakness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-026-08139-1","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:57:13Z","timestamp":1777571833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Management of suicidal crisis in an adolescent with Becker muscular dystrophy: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Hongying","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoxiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"10","key":"8139_CR1","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1007\/s00415-023-11837-5","volume":"270","author":"A Magot","year":"2023","unstructured":"Magot A, Wahbi K, Leturcq F, Jaffre S, P\u00e9r\u00e9on Y, Sole G, French BMD, Working Group. Diagnosis and management of Becker muscular dystrophy: the French guidelines. J Neurol. 2023;270(10):4763\u201381. https:\/\/doi.org\/10.1007\/s00415-023-11837-5.","journal-title":"J Neurol"},{"issue":"1\u20132","key":"8139_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jns.2014.10.030","volume":"347","author":"M Monforte","year":"2014","unstructured":"Monforte M, Mercuri E, Laschena F, Ricci E, Tasca G. Calf muscle involvement in Becker muscular dystrophy: when size does not matter. J Neurol Sci. 2014;347(1\u20132):301\u20134. https:\/\/doi.org\/10.1016\/j.jns.2014.10.030.","journal-title":"J Neurol Sci"},{"issue":"12","key":"8139_CR3","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1016\/j.apmr.2022.05.015","volume":"103","author":"C Pascual-Morena","year":"2022","unstructured":"Pascual-Morena C, Cavero-Redondo I, Reina-Guti\u00e9rrez S, Saz-Lara A, L\u00f3pez-Gil JF, Mart\u00ednez-Vizca\u00edno V. Prevalence of neuropsychiatric disorders in Duchenne and Becker muscular dystrophies: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2022;103(12):2444\u201353. https:\/\/doi.org\/10.1016\/j.apmr.2022.05.015.","journal-title":"Arch Phys Med Rehabil"},{"issue":"12","key":"8139_CR4","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.nmd.2019.09.006","volume":"29","author":"M Mori-Yoshimura","year":"2019","unstructured":"Mori-Yoshimura M, Mizuno Y, Yoshida S, Ishihara N, Minami N, Morimoto E, et al. Psychiatric and neurodevelopmental aspects of Becker muscular dystrophy. Neuromuscul Disord. 2019;29(12):930\u20139. https:\/\/doi.org\/10.1016\/j.nmd.2019.09.006.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"8139_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/muscles4040059","volume":"4","author":"V Baldini","year":"2025","unstructured":"Baldini V, Varallo G, Nuredini A, Tupler R, Valsecchi A, Nizzardo M, et al. The psychological burden of neuromuscular diseases: a narrative review of anxiety, depression, coping, and quality of life. Muscles. 2025;4(4):59. https:\/\/doi.org\/10.3390\/muscles4040059.","journal-title":"Muscles"},{"issue":"4","key":"8139_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.braindev.2017.11.004","volume":"40","author":"M Mori-Yoshimura","year":"2018","unstructured":"Mori-Yoshimura M, Mizuno Y, Yoshida S, Minami N, Yonemoto N, Takeuchi F, et al. Social involvement issues in patients with Becker muscular dystrophy: a questionnaire survey of subjects from a patient registry. Brain Dev. 2018;40(4):268\u201377. https:\/\/doi.org\/10.1016\/j.braindev.2017.11.004.","journal-title":"Brain Dev"},{"key":"8139_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/AHMT.S125739","volume":"9","author":"JG Andrews","year":"2018","unstructured":"Andrews JG, Wahl RA. Duchenne and Becker muscular dystrophy in adolescents: current perspectives. Adolesc Health Med Ther. 2018;9:53\u201363. https:\/\/doi.org\/10.2147\/AHMT.S125739.","journal-title":"Adolesc Health Med Ther"},{"issue":"2","key":"8139_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/mus.28296","volume":"71","author":"N Truba","year":"2025","unstructured":"Truba N, Sorensen S, Bearden R, Haley B, Spray B, Kinnett K, et al. The BELS questionnaire: a novel screening tool for neurodevelopmental and psychiatric symptoms in pediatric dystrophinopathy. Muscle Nerve. 2025;71(2):153\u20138. https:\/\/doi.org\/10.1002\/mus.28296.","journal-title":"Muscle Nerve"},{"issue":"20","key":"8139_CR9","doi-asserted-by":"publisher","first-page":"5950","DOI":"10.1080\/09638288.2021.1955306","volume":"44","author":"DN O\u2019Dowd","year":"2022","unstructured":"O\u2019Dowd DN, Bostock EL, Smith D, Morse CI, Orme P, Payton CJ. The effects of 12 weeks\u2019 resistance training on psychological parameters and quality of life in adults with facioscapulohumeral, Becker, and limb-girdle dystrophies. Disabil Rehabil. 2022;44(20):5950\u20136. https:\/\/doi.org\/10.1080\/09638288.2021.1955306.","journal-title":"Disabil Rehabil"},{"issue":"4","key":"8139_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jamda.2017.12.098","volume":"19","author":"LJ Seppala","year":"2018","unstructured":"Seppala LJ, Wermelink AMAT, de Vries M, Ploegmakers KJ, van de Glind EMM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19(4):371. https:\/\/doi.org\/10.1016\/j.jamda.2017.12.098.","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"8139_CR11","doi-asserted-by":"publisher","first-page":"glae263","DOI":"10.1093\/gerona\/glae263","volume":"80","author":"D O\u2019Donnell","year":"2025","unstructured":"O\u2019Donnell D, Moriarty F, Lavan A, Kenny RA, Briggs R. The association between psychotropic medication use and gait and mobility impairment in community-dwelling older people: data from The Irish Longitudinal Study on Ageing (TILDA). J Gerontol Biol Sci Med Sci. 2025;80(5):glae263. https:\/\/doi.org\/10.1093\/gerona\/glae263.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"5","key":"8139_CR12","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1176\/appi.ajp.162.5.977","volume":"162","author":"CH Kellner","year":"2005","unstructured":"Kellner CH, Fink M, Knapp R, Petrides G, Husain M, Rummans T, et al. Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry. 2005;162(5):977\u201382. https:\/\/doi.org\/10.1176\/appi.ajp.162.5.977.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"8139_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.nmd.2004.10.017","volume":"15","author":"W Klingler","year":"2005","unstructured":"Klingler W, Lehmann-Horn F, Jurkat-Rott K. Complications of anaesthesia in neuromuscular disorders. Neuromuscul Disord. 2005;15(3):195\u2013206. https:\/\/doi.org\/10.1016\/j.nmd.2004.10.017.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"8139_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ajmg.a.30617","volume":"134A","author":"KM Dent","year":"2005","unstructured":"Dent KM, Dunn DM, von Niederhausern AC, Aoyagi AT, Kerr L, Bromberg MB, et al. Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort. Am J Med Genet A. 2005;134A(3):295\u20138. https:\/\/doi.org\/10.1002\/ajmg.a.30617.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"8139_CR15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jaac.2025.06.012","volume":"65","author":"S Alemany","year":"2026","unstructured":"Alemany S, Bosch R, Soler Artigas M, Szekely E, Pina-Camacho L, Rovira P, et al. Exploring the behavioral and emotional manifestation of polygenic risk for psychiatric disorders among schoolchildren. J Am Acad Child Adolesc Psychiatry. 2026;65(4):605\u201317. https:\/\/doi.org\/10.1016\/j.jaac.2025.06.012.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"8139_CR16","doi-asserted-by":"publisher","DOI":"10.13201\/j.issn.2096-7993.2021.05.013","author":"L Yang","year":"2021","unstructured":"Yang L, Ding W, Wu M. [Anxiety and depression state among patients with different type of vertigo and dizziness]. Za Zhi. 2021;35(5):440\u20133. https:\/\/doi.org\/10.13201\/j.issn.2096-7993.2021.05.013. Chinese. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke."},{"key":"8139_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13023-014-0220-7","volume":"10","author":"X Li","year":"2015","unstructured":"Li X, Zhao L, Zhou S, Hu J, Tian T, Zhang C, et al. A comprehensive database of Duchenne and Becker muscular dystrophy patients (0\u201318 years old) in East China. Orphanet J Rare Dis. 2015;10:5. https:\/\/doi.org\/10.1186\/s13023-014-0220-7.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"8139_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/mus.26750","volume":"61","author":"JT Lambert","year":"2020","unstructured":"Lambert JT, Darmahkasih AJ, Horn PS, Rybalsky I, Shellenbarger KC, Tian C, et al. Neurodevelopmental, behavioral, and emotional symptoms in Becker muscular dystrophy. Muscle Nerve. 2020;61(2):156\u201362. https:\/\/doi.org\/10.1002\/mus.26750.","journal-title":"Muscle Nerve"},{"key":"8139_CR19","doi-asserted-by":"publisher","first-page":"104648","DOI":"10.1016\/j.neubiorev.2022.104648","volume":"137","author":"A Ferrero","year":"2022","unstructured":"Ferrero A, Rossi M. Cognitive profile and neuropsychiatric disorders in Becker muscular dystrophy: a systematic review of literature. Neurosci Biobehav Rev. 2022;137:104648. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104648.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"8139_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10964-021-01536-7","volume":"51","author":"R Potterton","year":"2022","unstructured":"Potterton R, Austin A, Robinson L, Webb H, Allen KL, Schmidt U. Identity development and social-emotional disorders during adolescence and emerging adulthood: a systematic review and meta-analysis. J Youth Adolesc. 2022;51(1):16\u201329. https:\/\/doi.org\/10.1007\/s10964-021-01536-7.","journal-title":"J Youth Adolesc"},{"issue":"2","key":"8139_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s42843-022-00059-4","volume":"48","author":"K Russo","year":"2022","unstructured":"Russo K. Assessment and treatment of adolescents with chronic medical conditions. J Health Serv Psychol. 2022;48(2):69\u201378. https:\/\/doi.org\/10.1007\/s42843-022-00059-4.","journal-title":"J Health Serv Psychol"},{"issue":"6","key":"8139_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.acap.2017.02.002","volume":"17","author":"LC Jones","year":"2017","unstructured":"Jones LC, Mrug S, Elliott MN, Toomey SL, Tortolero S, Schuster MA. Chronic physical health conditions and emotional problems from early adolescence through midadolescence. Acad Pediatr. 2017;17(6):649\u201355. https:\/\/doi.org\/10.1016\/j.acap.2017.02.002.","journal-title":"Acad Pediatr"},{"issue":"9820","key":"8139_CR23","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S0140-6736(11)60871-4","volume":"379","author":"A Thapar","year":"2012","unstructured":"Thapar A, Collishaw S, Pine DS, Thapar AK. Depression in adolescence. Lancet. 2012;379(9820):1056\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(11)60871-4.","journal-title":"Lancet"},{"issue":"3","key":"8139_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejpsy.2021.02.002","volume":"35","author":"I D\u00edaz-Oliv\u00e1n","year":"2021","unstructured":"D\u00edaz-Oliv\u00e1n I, Porras-Segovia A, Barrig\u00f3n ML, Jim\u00e9nez-Mu\u00f1oz L, Baca-Garc\u00eda E. Theoretical models of suicidal behaviour: a systematic review and narrative synthesis. Eur J Psychiatry. 2021;35(3):181\u201392. https:\/\/doi.org\/10.1016\/j.ejpsy.2021.02.002.","journal-title":"Eur J Psychiatry"},{"issue":"1","key":"8139_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/sltb.12335","volume":"48","author":"AD Neacsiu","year":"2018","unstructured":"Neacsiu AD, Fang CM, Rodriguez M, Rosenthal MZ. Suicidal behavior and problems with emotion regulation. Suicide Life Threat Behav. 2018;48(1):52\u201374. https:\/\/doi.org\/10.1111\/sltb.12335.","journal-title":"Suicide Life Threat Behav"},{"issue":"9","key":"8139_CR26","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.brat.2010.05.013","volume":"48","author":"J Johnson","year":"2010","unstructured":"Johnson J, Gooding PA, Wood AM, Taylor PJ, Pratt D, Tarrier N. Resilience to suicidal ideation in psychosis: positive self-appraisals buffer the impact of hopelessness. Behav Res Ther. 2010;48(9):883\u20139. https:\/\/doi.org\/10.1016\/j.brat.2010.05.013.","journal-title":"Behav Res Ther"},{"key":"8139_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.copsyc.2015.01.014","volume":"3","author":"KC Law","year":"2015","unstructured":"Law KC, Khazem LR, Anestis MD. The role of emotion dysregulation in suicide as considered through the ideation to action framework. Curr Opin Psychol. 2015;3:30\u20135. https:\/\/doi.org\/10.1016\/j.copsyc.2015.01.014.","journal-title":"Curr Opin Psychol"},{"key":"8139_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev.clinpsy.121208.131258","volume":"6","author":"MK Nock","year":"2010","unstructured":"Nock MK. Self-injury. Annu Rev Clin Psychol. 2010;6:339\u201363. https:\/\/doi.org\/10.1146\/annurev.clinpsy.121208.131258.","journal-title":"Annu Rev Clin Psychol"},{"key":"8139_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jad.2018.06.033","volume":"239","author":"G Kiekens","year":"2018","unstructured":"Kiekens G, Hasking P, Boyes M, Claes L, Mortier P, Auerbach RP, et al. The associations between non-suicidal self-injury and first onset suicidal thoughts and behaviors. J Affect Disord. 2018;239:171\u20139. https:\/\/doi.org\/10.1016\/j.jad.2018.06.033.","journal-title":"J Affect Disord"},{"issue":"12","key":"8139_CR30","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/jclp.20621","volume":"65","author":"JD Ribeiro","year":"2009","unstructured":"Ribeiro JD, Joiner TE. The interpersonal-psychological theory of suicidal behavior: current status and future directions. J Clin Psychol. 2009;65(12):1291\u20139. https:\/\/doi.org\/10.1002\/jclp.20621.","journal-title":"J Clin Psychol"},{"issue":"12","key":"8139_CR31","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1037\/bul0000123","volume":"143","author":"C Chu","year":"2017","unstructured":"Chu C, Buchman-Schmitt JM, Stanley IH, Hom MA, Tucker RP, Hagan CR, et al. The interpersonal theory of suicide: a systematic review and meta-analysis of a decade of cross-national research. Psychol Bull. 2017;143(12):1313\u201345. https:\/\/doi.org\/10.1037\/bul0000123.","journal-title":"Psychol Bull"},{"issue":"5","key":"8139_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1474-4422(18)30026-7","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, DMD Care Considerations Working Group, et al. Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol. 2018;17(5):445\u201355. https:\/\/doi.org\/10.1016\/S1474-4422(18)30026-7.","journal-title":"Lancet Neurol"},{"issue":"7","key":"8139_CR33","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/jama.292.7.807","volume":"292","author":"J March","year":"2004","unstructured":"March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, et al. Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292(7):807\u201320. https:\/\/doi.org\/10.1001\/jama.292.7.807.","journal-title":"JAMA"},{"issue":"23","key":"8139_CR34","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","volume":"21","author":"L Carton","year":"2015","unstructured":"Carton L, Cottencin O, Lapeyre-Mestre M, Geoffroy PA, Favre J, Simon N, et al. Off-label prescribing of antipsychotics in adults, children and elderly individuals: a systematic review of recent prescription trends. Curr Pharm Des. 2015;21(23):3280\u201397. https:\/\/doi.org\/10.2174\/1381612821666150619092903.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"8139_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1176\/appi.ajp.158.1.131","volume":"158","author":"RC Shelton","year":"2001","unstructured":"Shelton RC, Tollefson GD, Tohen M, Stahl S, Gannon KS, Jacobs TG, et al. A novel augmentation strategy for treating resistant major depression. Am J Psychiatry. 2001;158(1):131\u20134. https:\/\/doi.org\/10.1176\/appi.ajp.158.1.131.","journal-title":"Am J Psychiatry"},{"issue":"7","key":"8139_CR36","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1517\/14656566.4.7.1175","volume":"4","author":"RC Shelton","year":"2003","unstructured":"Shelton RC. The combination of olanzapine and fluoxetine in mood disorders. Expert Opin Pharmacother. 2003;4(7):1175\u201383. https:\/\/doi.org\/10.1517\/14656566.4.7.1175.","journal-title":"Expert Opin Pharmacother"},{"key":"8139_CR37","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jpsychires.2021.11.023","volume":"149","author":"J Berge","year":"2022","unstructured":"Berge J, Abri P, Andell P, Movahed P, Ragazan DC. Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality. J Psychiatr Res. 2022;149:352\u20138. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.11.023.","journal-title":"J Psychiatr Res"},{"key":"8139_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-41319-4_68-1","volume-title":"Suicide Risk Assessment and Prevention","author":"U Lewitzka","year":"2021","unstructured":"Lewitzka U. Anti-suicidal properties of lithium treatment. In: Pompili M, editor. Suicide Risk Assessment and Prevention. Cham: Springer; 2021. pp. 1\u201318. https:\/\/doi.org\/10.1007\/978-3-030-41319-4_68-1."},{"issue":"7","key":"8139_CR39","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3390\/jcm10071537","volume":"10","author":"S Sheikh","year":"2021","unstructured":"Sheikh S, Alvi U, Soliven B, Rezania K. Drugs that induce or cause deterioration of myasthenia gravis: an update. J Clin Med. 2021;10(7):1537. https:\/\/doi.org\/10.3390\/jcm10071537.","journal-title":"J Clin Med"},{"issue":"Pt B","key":"8139_CR40","doi-asserted-by":"publisher","first-page":"120462","DOI":"10.1016\/j.jad.2025.120462","volume":"393","author":"L Zheng","year":"2026","unstructured":"Zheng L, Xiong Y, Nie W, Si T. Glucose dysregulation signals in weight-neutral atypical antipsychotics: a pharmacovigilance-pharmacodynamic evaluation of FAERS data. J Affect Disord. 2026;393(Pt B):120462. https:\/\/doi.org\/10.1016\/j.jad.2025.120462.","journal-title":"J Affect Disord"},{"issue":"1","key":"8139_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/JCP.0000000000001318","volume":"41","author":"J Greger","year":"2021","unstructured":"Greger J, Aladeen T, Lewandowski E, Wojcik R, Westphal E, Rainka M, et al. Comparison of the metabolic characteristics of newer second generation antipsychotics: brexpiprazole, lurasidone, asenapine, cariprazine, and iloperidone with olanzapine as a comparator. J Clin Psychopharmacol. 2021;41(1):5\u201312. https:\/\/doi.org\/10.1097\/JCP.0000000000001318.","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"8139_CR42","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s40263-013-0105-7","volume":"27","author":"L Citrome","year":"2013","unstructured":"Citrome L. A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach. CNS Drugs. 2013;27(11):879\u2013911. https:\/\/doi.org\/10.1007\/s40263-013-0105-7.","journal-title":"CNS Drugs"},{"issue":"9","key":"8139_CR43","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s40263-016-0367-y","volume":"30","author":"C Bernagie","year":"2016","unstructured":"Bernagie C, Danckaerts M, Wampers M, De Hert M. Aripiprazole and acute extrapyramidal symptoms in children and adolescents: a meta-analysis. CNS Drugs. 2016;30(9):807\u201318. https:\/\/doi.org\/10.1007\/s40263-016-0367-y.","journal-title":"CNS Drugs"},{"issue":"7 Suppl","key":"8139_CR44","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1097\/00004583-200107001-00003","volume":"40","author":"American Academy of Child and Adolescent Psychiatry","year":"2001","unstructured":"American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with suicidal behavior. J Am Acad Child Adolesc Psychiatry. 2001;40(7 Suppl):S24\u201351. https:\/\/doi.org\/10.1097\/00004583-200107001-00003.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10","key":"8139_CR45","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/CHI.0b013e3181b5dbfe","volume":"48","author":"B Stanley","year":"2009","unstructured":"Stanley B, Brown G, Brent DA, Wells K, Poling K, Curry J, et al. Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability. J Am Acad Child Adolesc Psychiatry. 2009;48(10):1005\u201313. https:\/\/doi.org\/10.1097\/CHI.0b013e3181b5dbfe.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"8139_CR46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/PEC.0000000000001076","volume":"35","author":"EA Wharff","year":"2019","unstructured":"Wharff EA, Ginnis KB, Ross AM, White EM, White MT, Forbes PW. Family-based crisis intervention with suicidal adolescents: a randomized clinical trial. Pediatr Emerg Care. 2019;35(3):170\u20135. https:\/\/doi.org\/10.1097\/PEC.0000000000001076.","journal-title":"Pediatr Emerg Care"},{"key":"8139_CR47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.copsyc.2021.07.013","volume":"43","author":"SA Haslam","year":"2022","unstructured":"Haslam SA, Haslam C, Cruwys T, Jetten J, Bentley SV, Fong P, et al. Social identity makes group-based social connection possible: implications for loneliness and mental health. Curr Opin Psychol. 2022;43:161\u20135. https:\/\/doi.org\/10.1016\/j.copsyc.2021.07.013.","journal-title":"Curr Opin Psychol"},{"issue":"1","key":"8139_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/13284207.2023.2278792","volume":"28","author":"NM Wood","year":"2024","unstructured":"Wood NM, O\u2019Shea A, Num S, Johnson C, Sutherland CR, Edney LC, et al. Implementation of evidence-based group interventions in a community-based mental health service for self-harming and suicidal youth. Clin Psychol. 2024;28(1):49\u201361. https:\/\/doi.org\/10.1080\/13284207.2023.2278792.","journal-title":"Clin Psychol"},{"key":"8139_CR49","doi-asserted-by":"publisher","first-page":"e72141","DOI":"10.2196\/72141","volume":"27","author":"S Mekhuri","year":"2025","unstructured":"Mekhuri S, Dale C, Buchanan F, Hammash N, Ambreen M, Saha S, et al. Family caregivers of individuals with neuromuscular disease participating in a randomized controlled trial of a digital peer support program: nested qualitative study. J Med Internet Res. 2025;27:e72141. https:\/\/doi.org\/10.2196\/72141.","journal-title":"J Med Internet Res"},{"issue":"5","key":"8139_CR50","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1517\/17460441.2014.907790","volume":"9","author":"L Perez-Caballero","year":"2014","unstructured":"Perez-Caballero L, Torres-Sanchez S, Bravo L, Mico JA, Berrocoso E. Fluoxetine: a case history of its discovery and preclinical development. Expert Opin Drug Discov. 2014;9(5):567\u201378. https:\/\/doi.org\/10.1517\/17460441.2014.907790.","journal-title":"Expert Opin Drug Discov"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08139-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08139-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08139-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T02:36:55Z","timestamp":1781750215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08139-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8139"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08139-1","relation":{"references":[{"id-type":"doi","id":"10.13201\/j.issn.2096-7993.2021.05.013","asserted-by":"subject"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this case report was obtained from the Jiangxi Mental Hospital Ethics Committee (approval no. 202600401). This study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent to participate was obtained from the patient and his legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient and his legal guardians for the publication of this case report and any accompanying clinical information. A copy of the written consent is available for review by the Editor on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"476"}}